Skip to content
Eyes — Anti-VEGF injectionsATC S01LA04

Ranibizumab

Prescription onlyWHO essential medicine

Anti-VEGF eye injection for macular degeneration and diabetic eye disease.

Starts working
Weeks
Half-life
About 9 days (vitreous)
In use since
—
Pregnancy
Use with caution

Overview

Ranibizumab is injected into the eye to block VEGF. It treats wet age-related macular degeneration, diabetic macular oedema and retinal vein occlusion. Biosimilars are available.

Conditions it's used for

How it works

Stops abnormal blood vessels leaking in the retina.

Ranibizumab belongs to the Anti-VEGF injections. How Anti-VEGF injections work: block the signal that grows fragile, leaky blood vessels under the retina.

Uses

  • Wet age-related macular degeneration
  • Diabetic macular oedema
  • Retinal vein occlusion
  • Myopic choroidal neovascularisation

Available as: intravitreal injection.

Typical dose

Adults
0.5 mg injected into the eye monthly, then as needed or at extended intervals.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Eye pain
  • Floaters
  • Redness
  • Raised eye pressure

Serious — get medical help

Uncommon, but need prompt attention

  • Endophthalmitis (serious eye infection)
  • Retinal detachment
  • Arterial clots (rare)

Warnings

  • Report eye pain, vision loss or redness after injection immediately

Who should avoid it

  • Active eye infection
  • Active intraocular inflammation

Interactions

  • Verteporfin — timing
Check Ranibizumab against your own medicines

Using it safely

Alcohol
Usually no problem in moderation. No specific interaction.
Food and drink
Not applicable.
If you miss a dose
Rebook the next injection.
Stopping it
Follow your retina specialist.
Driving
Do not drive until vision recovers after injection.
Tests and checks
Vision; Eye pressure
If too much is taken
Raised eye pressure; hospital review.
Storage
Refrigerate.
Legal status
United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)

Pregnancy and breastfeeding

Pregnancy

Use with caution

Limited data; specialist decision.

Breastfeeding

Use with caution

Limited data.

Special groups

Kidney disease
Not generally used.
Liver disease
No adjustment.
Older adults
Standard dosing.

Brand names

United States
Lucentis, Byooviz, Cimerli
United Kingdom
Lucentis, Ranivisio
India
Lucentis, Razumab, Ranibizumab biosimilars
Australia
Lucentis

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Do I need a prescription for Ranibizumab?

Yes — Ranibizumab is prescription-only in most countries.

Can I take Ranibizumab during pregnancy?

Use with caution. Limited data; specialist decision. Always check with a doctor or midwife.

How quickly does Ranibizumab work?

Weeks.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.